Skip to content
Menu

NovoCure Limited NVCR

Full chart Compare
Set alert

Price alert · NVCR

All alert types
10.71 USD +0.02 (+0.19%)

Regular-session close

10.71 0.00 0.00%

After hours · Nov 20, 5:25 PM ET

10.61 Day range 11.06
9.82 52-week range 21.45
YTD
-17.17%
1 year
-6.54%

5D -0.93 (-7.99%)

10.501111.50MonTueWedThuFri10.71
Market cap
1.25B
Revenue (ttm)
725.39M
Profit margin
-16.78%
EPS (ttm)
-1.06
Shares out
116.92M
Forward P/E
-14.72
YTD return
-17.17%
1-year return
-6.54%
50-day average
14.40
200-day average
14.77
Volume
1.64M
Avg volume
1.51M
Open
10.61
Previous close
10.69
Day's range
10.61 – 11.06
52-week range
9.82 – 21.45
Beta
1.08
Analysts
Buy
Price target
26.14 (+144.1%)
Earnings date
Feb 25, 2027

Key statistics

Enterprise value
1.02B
Price / sales
1.73
Price / book
3.44
Revenue growth
15.70%
Free cash flow
9.00M
Total cash
463.48M
Total debt
231.55M
Return on equity
-35.19%
Short % of float
14.91%

Fundamental scorecard

9 of 25 checks passed on NVCR’s reported financials

ValueGrowthProfitabilityHealthDividend

9of 25 checks passed

  • Value 2 of 5
  • Growth 3 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
NVCR Revenue — quarterly 193.40M
NVCR Net income — quarterly -10.44M
NVCR EPS — quarterly -0.09

Earnings

NVCR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 25, 2027Dec 30, 2026-0.23———
Oct 29, 2026Sep 30, 2026-0.23487-0.09+0.14+61.68%
Jul 23, 2026Jun 30, 2026-0.33153-0.13+0.20+60.79%
Apr 30, 2026Mar 31, 2026-0.51219-0.62-0.11-21.05%
Feb 26, 2026Dec 31, 2025-0.41-0.22+0.19+46.34%
Oct 30, 2025Sep 30, 2025-0.42-0.33+0.09+21.43%

Upgrades / downgrades

NVCR analyst upgrades and downgrades
DateFirmActionFromTo
Nov 10, 2026Ladenburg ThalmannmainBuyBuy
Nov 10, 2026WedbushmainNeutralNeutral
Oct 30, 2026Wells FargomainEqual-WeightEqual-Weight
Oct 30, 2026Evercore ISI GroupmainOutperformOutperform
Jul 24, 2026WedbushmainNeutralNeutral
Jul 23, 2026HC Wainwright & Co.mainBuyBuy

About NovoCure Limited

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Sector
Healthcare
Industry
Medical Devices
Country
Switzerland
Website
novocure.com

News

Your note

Sign in to keep a note on NVCR — it syncs with the Stock Master app.

Insider holders

NVCR insider holders
InsiderRelationLatest transactionDateShares held
BEN ARYE BARAKGeneral CounselStock Award(Grant)Jun 29, 2026243,752
BRACKMANN CHRISTOPHChief Financial OfficerSaleNov 8, 2026175,499
CORDOVA ASHLEYFormerStock Award(Grant)Feb 26, 2026440,208
DANZIGER ASAFDirectorStock Award(Grant)Jun 29, 2026416,742
DOYLE WILLIAM FOfficer and DirectorStock Award(Grant)Mar 2, 2026328,397
LEONARD FRANCIS XAVIER IIChief Executive OfficerStock Award(Grant)Jun 29, 2026461,425

Institution ownership

NVCR institution ownership
Holder% heldSharesValueReported
FMR, LLC14.86%17,375,855186.10MSep 29, 2026
Blackrock Inc.10.15%11,863,861127.06MSep 29, 2026
Soleus Capital Management, L.P.8.06%9,425,776100.95MSep 29, 2026
Vanguard Portfolio Management LLC5.55%6,493,76769.55MSep 29, 2026
Vanguard Capital Management LLC4.21%4,923,98252.74MSep 29, 2026
Morgan Stanley4.02%4,697,12050.31MSep 29, 2026

Fund ownership

NVCR fund ownership
Holder% heldSharesValueReported
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund5.02%5,874,49662.92MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.99%3,490,92037.39MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.36%2,762,75229.59MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.16%2,521,41727.00MJun 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund1.49%1,741,74518.65MSep 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund1.33%1,550,90016.61MSep 29, 2026